|
|
|
|
||
Re: We have a Phase 3 B trial examining the efficacy of Sipuluecel-T in Early stage Hormone Sensitive Prostate CancerWould this result not imply the trial a success with a 4.5 year survival advantage. I believe that this phase 111 B trial is intended for Label expansion. Is it possible the company already has applied to the FDA for this indication? |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
467877 | Re: We have a Phase 3 B trial examining the efficacy of Sipuluecel-T in Early stage Hormone Sensitive Prostate Cancer | ridge runner | 1 | 7/21/2014 7:00:16 PM |